Microbeam X-ray fluorescence mapping of Cu and Fe in human prostatic carcinoma cell lines using synchrotron radiation
DOI:
https://doi.org/10.15392/bjrs.v7i2A.608Keywords:
X-Ray, microfluorescence, cancerAbstract
Cancer is a worldwide public health problem and prostate cancer continues to be one of the most common fatal cancers in men. Copper plays an important role in the aetiology and growth of tumours however, whether intratumoral copper is actually elevated in prostate cancer patients has not been established. Iron, an important trace element, plays a vital function in oxygen metabolism, oxygen uptake, and electron transport in mitochondria, energy metabolism, muscle function, and hematopoiesis. The X-ray microfluorescence technique (μXRF) is a rapid and non-destructive method of elemental analysis that provides useful elemental information about samples without causing damage or requiring extra sample preparations. This study investigated the behavior of cells in spheroids of human prostate cells, tumour cell line (DU145) and normal cell line (RWPE-1), after supplementation with zinc chloride by 24 hours using synchrotron X-ray microfluorescence (μSRXRF). The measurements were performed with a standard geometry of 45º of incidence, excited by a white beam using a pixel of 25 μm and a time of 300 ms/pixel at the XRF beamline at the Synchrotron Light.- Views: 96
- PDF Downloads: 119
Downloads
References
Web Site
National Cancer Institute José Alencar Gomes da Silva. Estimate 2016: Cancer Incidence in Bra-zil. 2016. Available at: http://www.inca.gov.br/wcm/dncc/2015/estimativa-2016.pdf>.
Journal
GOUGH, Mallory et al. The E1 copper binding domain of full-length amyloid precursor protein mitigates copper-induced growth inhibition in brain metastatic prostate cancer DU145 cells. Bio-chemical And Biophysical Research Communications, v. 453, p. 741-747, 2014.
Journal
DENOYER, Delphine et al. Heterogeneous copper concentrations in cancerous human prostate tis-sues. The Prostate, v. 75, p. 1510-1517, 2015.
Journal
DENOYER, Delphine et al. Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution. Oncotarget, v. 7, p. 37064-37080, 2016.
Journal
LUDWIG, Heinz et al. Iron metabolism and iron supplementation in cancer patients. Wiener Klinische Wochenschrift, v. 127, p. 907-919, 2015.
Journal
RODRIGO, Miguel Angel Merlos et al. Zinc and metallothionen in prostate cancer: A review. Journal Of Metallomics And Nanotechnologies, v. 2, p. 58-63, 2015.
Journal
COSTELLO, Leslie C.; FRANKLIN, Renty B. A comprehensive review of the role of zinc in nor-mal prostate function and metabolism; and its implications in prostate cancer. Archives Of Bio-chemistry And Biophysics, v. 611, p. 100-112, 2016.
Journal
JOHNSON, Leslie A. et al. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods, v. 52, p. 316-321, 2010.
Journal
LANKOSZ, M. et al. Research in quantitative microscopic X-ray fluorescence analysis. Spectrochimica Acta Part B: Atomic Spectroscopy, v. 59, p. 1517-1521, 2004.
Journal
RAK, Margaret et al. X-ray microfluorescence (μXRF) imaging of Aspergillus nidulans cell wall mutants reveals biochemical changes due to gene deletions. Analytical And Bioanalytical Chem-istry, v. 406, p. 2809-2816, 2014.
Journal
ROCHA, K.M.J et al. H Zinc distribution in human prostate carcinoma cell line using synchrotron X-ray microfluorescence. X-Ray Spectrometry, v. 46, p. 403-411, 2017.
Journal
XUE, Dong et al. Decreased expression of ferroportin in prostate cancer. Oncology Letters, v. 10, p. 913-916, 2015.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Brazilian Journal of Radiation Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing: The BJRS articles are licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/